FDA Inspection
Celltex Therapeutics CorporationCelltex Therapeutics Corporation – FDA Inspection, Apr 27, 2012
Record Details
This FDA Inspection record concerns Celltex Therapeutics Corporation, with an inspection on April 27, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 27, 2012
- Product Type
- Biologics
View Company Profile
ID · 303600a8-6d48-4cd5-afc6-2fd1e8e01a71
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 781924
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
14- 21 CFR 211.188Prepared for each batch, include complete information
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.196Distribution Record Requirements
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.80(d)Status of Each Lot Identified
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 1271.370(a)Clear and accurate label
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.105(b)Distinctive ID or code not recorded in batch record
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.